| # |
Characteristics |
Free-living healthy senior subjects |
Hypercholesterolemic subjects |
| |
|
Group-A |
Group-B |
Group-C |
Group-D |
| 1 |
Subjects |
|
|
|
|
| |
Males (n) |
11 |
11 |
22 |
22 |
| |
Females (n) |
5 |
5 |
10 |
10 |
| |
Total (males + females) n = |
16 |
16 |
32 |
32 |
| 2 |
Age (years) |
|
|
|
|
| |
Males |
66.82 ± 2.33* |
65.73 ± 1.89* |
58.50 ± 0.66* |
57.68 ± 1.15* |
| |
Females |
68.00 ± 4.44 |
68.00 ± 1.10 |
57.80 ± 0.87 |
56.60 ± 1.50 |
| |
Total (males + females) |
65.41 ± 3.39 |
66.86 ± 1.50 |
58.15 ± 0.77 |
57.14 ± 1.33 |
| 3 |
Body weight (kg) |
|
|
|
|
| |
Males |
79.36 ± 1.50 |
81.45 ± 0.97 |
72.32 ± 0.87 |
72.64 ± 0.65 |
| |
Females |
78..00 ± 1.87 |
79.60 ± 1.21 |
73.00 ± 1.26 |
75.00 ± 1.67 |
| |
Total (males + females) |
78.68 ± 1.69 |
80.53 ± 1.09 |
72.66 ± 1.07 |
73.82 ± 1.16 |
| 4 |
Body mass index (kg/m2) |
|
|
|
|
| |
Males |
24.82 ± 0.38 |
26.07 ± 0.37 |
23.04 ± 0.29 |
24.16 ± 0.32 |
| |
Females |
25.67 ± 0.92 |
31.08 ± 0.81 |
27.07 ± 0.75 |
27.26 ± 0.68 |
| |
Total (males + females) |
25.25 ± 0.65 |
28.57 ± 2.51 |
25.05 ± 2.20 |
25.71 ± 0.50 |
| 5 |
Initial height (m) |
|
|
|
|
| |
Males |
1.79 ± 0.01 |
1.77 ± 0.01 |
1.77 ± 0.01 |
1.74 ± 0.01 |
| |
Females |
1.75 ± 0.04 |
1.60 ± 0.01 |
1.65 ± 0.03 |
1.66 ± 0.03 |
| |
Total (males + females) |
1.77 ± 0.03 |
1.69 ± 0.01 |
1.71 ± 0.02 |
1.70 ± 0.02 |
| 6 |
Blood pressure (mmHg) |
|
|
|
|
| |
Males |
|
|
|
|
| |
Pre-treatment (systolic/diastolic) |
134.55 ± 1.42/87.73 ± 1.04 |
137.73 ± 1.56/88.64 ± 1.92 |
140.45 ± 1.14/90.68 ± 1.24 |
138.64 ± 1.00/91.59 ± 0.83 |
| |
Post-treatment |
130.00 ± 0.95/81.82 ± 0.76 |
135.00 ± 1.51/85.91 ± 1.13 |
135.00 ± 0.99/84.09 ± 0.91 |
135.23 ± 0.96/87.50 ± 1.17 |
| |
Females |
|
|
|
|
| |
Pre-treatment |
138.00 ± 2.00/88.00 ± 3.00 |
138.00 ± 2.00/91.00 ± 2.92 |
143.00 ± 1.70/92.50 ± 2.01 |
139.00 ± 1.63/90.00 ± 1.97 |
| |
Post-treatment |
133.00 ± 2.00/83.00 ± 1.22 |
133.00 ± 2.00/88.00 ± 1.22 |
135.50 ± 1.89/86.00 ± 1.45 |
134.00 ± 1.45/85.50 ± 1.74 |
| |
Total (males + females) |
|
|
|
|
| |
Pre-treatment |
136.00 ± 1.70/87.90 ± 2.02 |
137.86 ± 1.78/89.82 ± 2.42 |
141.73 ± 1.42/91.59 ± 1.63 |
138.82 ± 1.32/90.80 ± 1.40 |
| |
Post-treatment |
131.50 ± 1.50/82.40 ± 0.99 |
134.00 ± 1.76/86.95 ± 1.18 |
135.25 ± 1.44/85.05 ± 1.18 |
134.61 ± 1.21/86.50 ± 1.46 |
| 7 |
Initial total cholesterol (mmol/L) |
|
|
|
|
| |
Males |
4.46 ± 0.13 |
4.03 ± 0.20 |
5.91 ± 0.08 |
6.06 ± 0.12 |
| |
Females |
4.51 ± 0.24 |
4.20 ± 0.35 |
6.11 ± 0.14 |
6.52 ± 0.17 |
| |
Total (males + females) |
4.48 ± 0.19 |
4.12 ± 0.28 |
6.01 ± 0.11 |
6.29 ± 0.15 |
| 8 |
Initial triglycerides (mmol/L) |
|
|
|
|
| |
Males |
1.37 ± 0.13 |
1.16 ± 0.07 |
1.74 ± 0.14 |
2.16 ± 0.13 |
| |
Females |
1.68 ± 0.32 |
1.34 ± 0.19 |
1.66 ± 0.17 |
2.19 ± 0.19 |
| |
Total (males + females) |
1.52 ± 0.23 |
1.25 ± 0.13 |
1.70 ± 0.16 |
2.17 ± 0.16 |
